Loading...
Loading...
Among the 4 tracked institutional investors we monitor, CYTXEUR (PLUS THERAPEUTICS INC) is held with a combined value of $1.58M across 4,796,278 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.17M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter.
Total Institutional Value
$1.58M
Total Shares Held
4,796,278
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.17M | 0.00% | New |
| 2 | BlackRock, Inc. | $288.84K | 0.00% | - |
| 3 | STATE STREET CORP | $76.24K | 0.00% | - |
| 4 | MILLENNIUM MANAGEMENT LLC | $44.16K | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of CYTXEUR with a position worth $1.17M, representing 0.00% of their portfolio. In total, 4 institutional investors hold CYTXEUR with a combined value of $1.58M.
In the most recent quarter, 2 funds opened a new position in CYTXEUR.
Institutional investors hold $1.58M worth of CYTXEUR stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $1.17M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CYTXEUR, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CYTXEUR positions.